lipid nanoparticle
| 5 min read
Paolo Martini leads the biotech company’s rare disease research program with the hope of developing the very first treatments for genetic metabolic disorders.
| 5 min read
Scientists developed an alternative to bone marrow transplantation by using technology similar to that of the COVID-19 mRNA vaccines.
| 4 min read
Robert Georgantas aims to expand the development of mRNA-based vaccines for a range of infectious diseases and cancers.
Page 1 of 1 - 3 Total Items
